CENTER ID: | HepyC.10201.a |
ORGANISM: | Helicobacter pylori G27 |
ASSOCIATED DISEASE: | |
CURRENT STATUS: | crystallized |
COMMUNITY REQUEST: | True |
NIH RISK GROUP: | 2 |
SELECT AGENT: | False |
NIH PRIORITY pathogens category: |
I |
CENTER REFERENCE ID |
DOMAIN/REGION DESCRIPTION |
INFO | AA START |
AA STOP |
ORDER MATERIAL |
---|---|---|---|---|---|
HepyC.10201.a.B2.GE41013 | soluble domain #1 | 1 | 444 | ||
HepyC.10201.a.B3.GE41014 | soluble domain #2 | 465 | 650 |
CENTER REFERENCE ID |
DOMAIN/REGION DESCRIPTION |
INFO | AA START |
AA STOP |
ORDER MATERIAL |
---|---|---|---|---|---|
HepyC.10201.a.B3.PW38236 | soluble domain #2 | 465 | 650 |
RESOURCE | REFERENCE ID |
---|---|
BV-BRC: | fig|563041.6.peg.1040 |
UniProt: | B5Z811 |
HARVESTED ON: | 1/4/2017 |
SEQUENCED ON: | 1/5/2017 |
EXPECTED MW: | 52kDa |
OBSERVED MW: | 51kDa |
ANTIBIOTIC MARKER: | ampicillin |
COUNT OF EXPRESSION COLONIES: | Many (50-100) |
TOTAL EXPRESSION LEVEL: | Moderate Expression |
SOLUBLE EXPRESSION LEVEL | No Expression |
EXPRESSION HOST: | BL 21 (DE3) Rosetta |
SEQUENCING RESULT: | |
PERCENT IDENTITY: | 99 |
PERCENT COVERAGE: | 98 |
HARVESTED ON: | 1/4/2017 |
SEQUENCED ON: | 1/5/2017 |
EXPECTED MW: | 22kDa |
OBSERVED MW: | 22kDa |
ANTIBIOTIC MARKER: | ampicillin |
COUNT OF EXPRESSION COLONIES: | Many (50-100) |
TOTAL EXPRESSION LEVEL: | Moderate Expression |
SOLUBLE EXPRESSION LEVEL | Low Expression |
EXPRESSION HOST: | BL 21 (DE3) Rosetta |
SEQUENCING RESULT: | |
PERCENT IDENTITY: | 100 |
PERCENT COVERAGE: | 100 |
PURIFICATION DATe: | 3/27/2017 |
CONCENTRATION: | 3.3mg/ml |
OBSERVED MW: | 23kDa |
EXPRESSION LEVEL: | Low Expression |
PROTEIN PURIFICATION BUFFER: | 25 mM HEPES pH 8.0, 500 mM NaCl, 5% Glycerol , 2 mM DTT, and 0.025% Azide |
EXPRESSION HOST: | BL 21 (DE3) Rosetta |
VIAL COUNT (approx.): | 27 |
VIAL VOLUME: | 200µl |
PERCENT IDENTITY: | 100 |
PERCENT COVERAGE: | 100 |